Orchestra BioMed
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $836 | $868 | $253 | $987 |
Gross Profit | 790 | 824 | 195 | 919 |
EBITDA | -19,327 | -18,921 | -16,593 | -16,266 |
EBIT | -19,327 | -19,004 | -16,677 | -16,342 |
Net Income | -19,363 | -18,755 | -16,155 | -15,426 |
Net Change In Cash | 836 | 868 | 253 | 987 |
Free Cash Flow | -15,561 | -16,728 | -13,644 | -13,768 |
Cash | 18,749 | 18,348 | 22,261 | 25,605 |
Basic Shares | 38,392 | 38,235 | 38,064 | 37,621 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,638 | $2,760 | $3,533 | $-782 |
Gross Profit | 2,434 | 2,574 | 3,211 | -981 |
EBITDA | -64,301 | -51,219 | -32,435 | -21,618 |
EBIT | -64,609 | -51,506 | -32,657 | -21,799 |
Net Income | -61,024 | -49,120 | -33,608 | -23,014 |
Net Change In Cash | 2,638 | 2,760 | 3,533 | -782 |
Free Cash Flow | -50,847 | -46,205 | -29,880 | -19,703 |
Cash | 22,261 | 30,559 | 19,784 | 9,938 |
Basic Shares | 36,821 | 33,225 | 14,988 | 20,450 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.50 |
2025-03-31 | -$0.49 |
2024-12-31 | -$0.42 |
2024-09-30 | -$0.41 |
